Egy Group
FDA import alert and refusal historyEl Ahram, EgyptFEI 3005463767
As of October 26, 2026, Egy Group (El Ahram, Egypt) is on the red list of FDA Import Alert 99-08 (Processed human and animal foods: pesticides) for dried limes, published by FDA on August 5, 2011, is also listed on Import Alert 99-19 (red list), and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-08 · red listIA 99-19 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Egy Group
2 records, newest first. Each line links to the FDA page it came from.
2011
- Import alert listingListed on Import Alert 99-08red listDried LimesSource
- Import alert listingListed on Import Alert 99-19red listAnise Seed; FennelSource
Questions about Egy Group
- Is Egy Group on an FDA import alert?
- Yes. As of October 26, 2026, Egy Group is on the red list of FDA Import Alert 99-08, “Processed human and animal foods: pesticides”, for dried limes; FDA published the listing on August 5, 2011.
- Has FDA refused shipments from Egy Group?
- No FDA import refusals for Egy Group appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Egy Group's FEI number?
- Egy Group's FDA Establishment Identifier (FEI) is 3005463767.
- Can shipments from Egy Group still enter the U.S.?
- Shipments of dried limes from Egy Group can be detained without physical examination under Import Alert 99-08; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Egy Group?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.